Literature DB >> 35261220

OShnscc: a novel user-friendly online survival analysis tool for head and neck squamous cell carcinoma based on RNA expression profiles and long-term survival information.

Guosen Zhang1, Qiang Wang2, Xinlei Qi1, Huimin Yang1, Xiaodong Su1, Manman Yang1, Chao Jiang1, Yang An1, Hong Zheng1, Lu Zhang1, Wan Zhu3, Jiancheng Guo4,5,6, Xiangqian Guo7.   

Abstract

Head and neck squamous cell carcinoma (HNSCC), as the most common type (>90%) of head and neck cancer, includes various epithelial malignancies that arise in the nasal cavity, oral cavity, pharynx, and larynx. In 2020, approximately 878 ‍ 000 new cases and 444 000 deaths linked to HNSCC occurred worldwide (Sung et al., 2021). Due to the associated frequent recurrence and metastasis, HNSCC patients have poor prognosis with a five-year survival rate of 40%-50% (Jou and Hess, 2017). Therefore, novel prognostic biomarkers need to be developed to identify high-risk HNSCC patients and improve their disease outcomes.

Entities:  

Keywords:  Head and neck squamous cell carcinoma; Kaplan-Meier curve; OShnscc; Online survival tool; Prognostic biomarker

Mesh：

Substances：

Year:  2022        PMID： 35261220      PMCID： PMC8913923          DOI： 10.1631/jzus.B2100512

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN： 1673-1581            Impact factor:   3.066


  17 in total

1.  The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer.

Authors:  Gunnar Wichmann; Maciej Rosolowski; Knut Krohn; Markus Kreuz; Andreas Boehm; Anett Reiche; Ulrike Scharrer; Dirk Halama; Julia Bertolini; Ulrike Bauer; Dana Holzinger; Michael Pawlita; Jochen Hess; Christoph Engel; Dirk Hasenclever; Markus Scholz; Peter Ahnert; Holger Kirsten; Alexander Hemprich; Christian Wittekind; Olf Herbarth; Friedemann Horn; Andreas Dietz; Markus Loeffler
Journal:  Int J Cancer       Date:  2015-07-06       Impact factor: 7.396

2.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

3.  Treatment delays, race, and outcomes in head and neck cancer.

Authors:  Arash O Naghavi; Michelle I Echevarria; Tobin J Strom; Yazan A Abuodeh; Kamran A Ahmed; Puja S Venkat; Andy Trotti; Louis B Harrison; B Lee Green; Kosj Yamoah; Jimmy J Caudell
Journal:  Cancer Epidemiol       Date:  2016-09-22       Impact factor: 2.984

Review 4.  Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment.

Authors:  Sara I Pai; William H Westra
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

Review 5.  Designing biomarker studies for head and neck cancer.

Authors:  Kelly Y Kim; Lisa M McShane; Barbara A Conley
Journal:  Head Neck       Date:  2014-07       Impact factor: 3.147

6.  High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.

Authors:  Deng Pan; Le Xu; Haiou Liu; Weijuan Zhang; Weisi Liu; Yidong Liu; Qiang Fu; Jiejie Xu
Journal:  Cancer Sci       Date:  2015-03-16       Impact factor: 6.716

7.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.

Authors:  Zefang Tang; Chenwei Li; Boxi Kang; Ge Gao; Cheng Li; Zemin Zhang
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

8.  An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.

Authors:  Jianfang Liu; Tara Lichtenberg; Katherine A Hoadley; Laila M Poisson; Alexander J Lazar; Andrew D Cherniack; Albert J Kovatich; Christopher C Benz; Douglas A Levine; Adrian V Lee; Larsson Omberg; Denise M Wolf; Craig D Shriver; Vesteinn Thorsson; Hai Hu
Journal:  Cell       Date:  2018-04-05       Impact factor: 41.582

9.  OSblca: A Web Server for Investigating Prognostic Biomarkers of Bladder Cancer Patients.

Authors:  Guosen Zhang; Qiang Wang; Mengsi Yang; Quan Yuan; Yifang Dang; Xiaoxiao Sun; Yang An; Huan Dong; Longxiang Xie; Wan Zhu; Yunlong Wang; Xiangqian Guo
Journal:  Front Oncol       Date:  2019-06-04       Impact factor: 6.244

10.  Development and Validation of Novel Biomarkers Related to M2 Macrophages Infiltration by Weighted Gene Co-Expression Network Analysis in Prostate Cancer.

Authors:  Ning Xu; Ru-Nan Dong; Ting-Ting Lin; Tian Lin; Yun-Zhi Lin; Shao-Hao Chen; Jun-Ming Zhu; Zhi-Bin Ke; Fei Huang; Ye-Hui Chen; Xue-Yi Xue
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.